Related by context. All words. (Click for frequent words.) 77 ribavirin RBV 76 alfa 2a 74 PegIFN RBV 73 severe neutropenia 73 peginterferon alfa 73 plus ribavirin 73 peginterferon 73 receiving INTRON 73 anthracycline taxane 73 virologic failure 73 pegylated interferon 72 pegylated interferon alpha 72 Peg IFN 72 PREZISTA r 72 abacavir lamivudine 72 APTIVUS r 71 HBeAg negative 71 peginterferon alfa 2b 71 dasatinib Sprycel ® 71 interferon therapy 71 mRCC 71 TMP SMX 71 adalimumab Humira 71 detectable HCV RNA 71 lenalidomide Revlimid R 71 invasive aspergillosis 71 Peginterferon Alfa 2a 71 neutropenia dehydration dyspnea 71 amoxicillin clavulanate 71 sustained virologic response 71 TNF antagonist 71 PEGINTRON TM 71 Pegasys ® 70 ritonavir boosted 70 docetaxel Taxotere ® 70 interferon alfa 2b 70 mycophenolate mofetil 70 HBeAg positive 70 pegylated interferon alfa 70 alkylating agent 70 peg IFN 70 trimethoprim sulfamethoxazole 70 certolizumab 70 FOLFOX6 70 genotypic resistance 70 VELCADE melphalan 70 Copegus ribavirin 70 anthracycline containing 70 chlorambucil 70 dacarbazine 70 peginterferon alfa 2a 70 pegylated interferon alfa 2a 70 mcg kg REBETOL 69 interferon ribavirin 69 Peginterferon alfa 2b 69 docetaxel chemotherapy 69 null responders 69 hemorrhagic cystitis 69 Doxil ® 69 voriconazole 69 Pegasys plus Copegus 69 pyrazinamide 69 Lactic acidosis 69 severe hypersensitivity reactions 69 HBeAg positive patients 69 protease inhibitor PI 69 recurrent glioblastoma multiforme 69 DOXIL 69 adriamycin 69 ACTEMRA TM 69 rizatriptan 69 FASLODEX 69 MAGE A3 ASCI 69 invasive candidiasis 69 relapsed MM 69 naïve HCV 69 Virologic 69 potentially hepatotoxic 69 recurrent genital herpes 69 achieve sustained virologic 69 myelodysplastic myeloproliferative diseases 69 pegylated interferons 69 NATRECOR ® 69 interferon alfa 2a 69 trastuzumab Herceptin ® 69 boosted protease inhibitor 68 Pegylated interferon 68 salmeterol fluticasone 68 tipranavir ritonavir 68 oral vancomycin 68 Pharmacokinetics PK 68 FOLFIRI 68 β blocker 68 elevated transaminases 68 posaconazole 68 virological failure 68 TEAEs 68 candidemia 68 PegIFN 68 TNF inhibitor 68 tumor lysis syndrome 68 alpha interferons 68 HBeAg seroconversion 68 ALT flares 68 divalproex sodium 68 nevirapine Viramune 68 HCV RESPOND 2 68 pyrexia mucositis sepsis febrile 68 anthracyclines taxanes 68 β blockers 68 SPRYCEL ® 68 lamivudine refractory patients 68 alpha 2b 68 3TC lamivudine Epivir 68 receiving immunosuppressive therapy 68 ZOLINZA 68 potent CYP#A# inhibitors 68 efalizumab 68 BARACLUDE ® 68 pegylated alpha interferon 68 severe renal impairment 68 COPD exacerbation 68 lopinavir r 68 hypomagnesemia 68 erlotinib Tarceva ® 68 EPIVIR 68 placebo dexamethasone 68 disease modifying antirheumatic 68 clodronate 68 PegIntron 68 patients coinfected 68 cidofovir 68 receiving VICTRELIS 68 indinavir 68 benazepril 68 bacillus Calmette Guerin 68 Infusion Reactions Severe 68 plus COPEGUS 68 tolterodine ER 68 metastatic GIST 68 cetuximab Erbitux R 68 drug eluting stent implantation 68 nadolol 68 alpha 2a 68 refractory NSCLC 68 5-FU/LV 68 peginterferon alfa 2a Pegasys 68 ATACAND 67 saline placebo 67 rFVIIa 67 thalidomide Thalomid 67 induce orthostatic hypotension 67 CCyR 67 fluticasone salmeterol 67 AZT zidovudine Retrovir 67 gemcitabine Gemzar 67 immunomodulatory therapy 67 HCV genotype 1 67 DMARD therapy 67 HBeAg + 67 APTIVUS ritonavir 67 administered concomitantly 67 concomitant antibiotics 67 cytopenias 67 achieved ACR# 67 acute GvHD 67 5 FU leucovorin 67 COPEGUS 67 fluvastatin 67 hepatic metastases 67 ertapenem 67 PEGylated anti 67 intravenous bisphosphonates 67 tenofovir emtricitabine 67 q#h 67 metastatic RCC 67 infliximab monotherapy 67 ergot derivatives 67 INFERGEN 67 ZIAGEN 67 severe hepatomegaly 67 cytotoxic therapy 67 FROVA 67 myopathy rhabdomyolysis 67 sorafenib Nexavar 67 PEG IFN 67 AMEVIVE 67 receiving prophylactic anticoagulation 67 DMARD 67 bendamustine 67 INVEGA ® 67 hepatic failure 67 idarubicin 67 FluCAM arm 67 Aptivus ® 67 mitoxantrone chemotherapy 67 estramustine 67 ß blockers 67 gemifloxacin 67 hypercalcemia 67 ritonavir boosted protease inhibitor 67 ribavirin USP 67 tirofiban 67 Navelbine ® 67 oxymorphone ER 67 pegylated interferon peg IFN 67 taxane chemotherapy 67 virological response 67 biologic DMARD 67 ORENCIA ® 67 Pegasys peginterferon alfa 2a 67 tipranavir 67 refractory gout 67 plus prednisone prednisolone 67 hepatitis C genotype 67 plus prednisone 67 achieved sustained virologic 67 leukemia AML 67 chronic HCV infection 67 INVANZ 67 ethambutol 67 doxazosin 67 TDF FTC 67 clomipramine 67 CAELYX 67 entecavir 67 azathioprine 67 sotalol 67 alkylating agents 67 mcg BID 66 virologic response 66 Ribavirin 66 heparin induced thrombocytopenia 66 hepatotoxicity 66 systemic corticosteroids 66 moderate renal impairment 66 HBeAg negative patients 66 dalteparin 66 metastatic malignant 66 undetectable HCV RNA 66 antiretroviral naive 66 zidovudine lamivudine 66 irinotecan containing 66 KRAS mutant tumors 66 flutamide 66 peginterferon alpha 2a 66 interferon gamma 1b 66 dexamethasone Decadron 66 fosamprenavir 66 Mg Uk 66 refractory chronic lymphocytic 66 interferon alfa 66 REVLIMID ® 66 4mg/kg 66 TO AVOID PREGNANCY WHILE 66 smoldering multiple myeloma 66 Mg Usa 66 Pegylated Interferon 66 CANCIDAS 66 8mg/kg 66 DMARDS 66 infusional 66 enfuvirtide 66 Telintra 66 adverse cytogenetics 66 mycophenolate mofetil MMF 66 Pemetrexed 66 pharmacokinetic interactions 66 fludarabine 66 amphotericin B 66 log# reduction 66 hypereosinophilic syndrome 66 ceftazidime 66 hematologic toxicity 66 MULTAQ 66 diabetic gastroparesis 66 antimuscarinic 66 nicardipine 66 CIMZIA TM certolizumab pegol 66 plus dexamethasone 66 severe exacerbations 66 baminercept 66 cisplatin gemcitabine 66 R lenalidomide 66 Chronic Hepatitis C 66 #mg BID [003] 66 anthracycline therapy 66 pegylated interferon alpha 2a 66 lenalidomide dexamethasone 66 virus HCV infection 66 mg QD 66 MYCAMINE 66 Fludara 66 anagrelide 66 Roche Pegasys 66 CHOP chemotherapy 66 #mg QD [002] 66 pegIFN 66 corticosteroid therapy 66 receiving VELCADE 66 RLAI 66 LPV r 66 Fludara ® 66 paliperidone ER 66 weekly subcutaneous injections 66 prior chemotherapy regimens 66 carboplatin paclitaxel 66 imipenem 66 superficial bladder cancer 66 Abrupt discontinuation 66 elotuzumab 66 TORISEL 66 piperacillin tazobactam 66 chronic HBV 66 REBETOL combination therapy 66 oral rivaroxaban 66 activated partial thromboplastin 66 renal toxicity 66 esophageal candidiasis 66 dosage regimens 66 primary hypercholesterolemia 66 virus HCV protease inhibitor 66 COMBIVIR 66 DMARDs 66 oral ridaforolimus 66 vincristine doxorubicin 66 Coadministration 66 oropharyngeal candidiasis OPC 66 CIMZIA TM 66 QT prolongation 66 VFEND 66 ULORIC 66 mycophenolic acid 66 Known hypersensitivity 66 Peginterferon 66 adefovir 66 mg/m2 dose 66 null responder HCV 66 discontinued Viread 66 haematologic 66 Traficet EN 66 q8h 66 mg kg dose 65 viral kinetics 65 QTc prolongation 65 elevated ALT 65 metastatic CRC 65 FUSILEV enhances 65 ABC/3TC 65 tolterodine 65 EXJADE 65 primidone 65 efavirenz EFV 65 REVLIMID lenalidomide 65 panitumumab Vectibix 65 SMZ TMP 65 Flu Cy 65 titrated glipizide 65 hypophosphatemia 65 FOLFOX 65 stavudine d4T 65 nephrotoxicity 65 imatinib therapy 65 ug dose 65 standard chemotherapy regimen 65 ARCOXIA 65 comparator arm 65 administered subcutaneously 65 Peginterferon alfa 2a 65 bone marrow suppression 65 #mg/day [002] 65 nitazoxanide 65 Amgen Neulasta R 65 recurrent VTE 65 DAPT 65 gemcitabine cisplatin 65 infusional 5-FU/LV 65 alefacept 65 K ras mutations 65 forodesine 65 idraparinux 65 Helicobacter pylori eradication 65 antiarrhythmic drug 65 COPD exacerbations 65 HES CEL 65 methotrexate monotherapy 65 #mg BID [001] 65 concomitant medications 65 PEGINTRON 65 INTELENCE 65 pentoxifylline 65 chronic eosinophilic leukemia 65 visilizumab 65 pyridostigmine 65 PEGylated Fab fragment 65 Noxafil 65 refractory CLL 65 lopinavir r arm 65 angiotensin converting enzyme inhibitor 65 atazanavir Reyataz 65 Elitek 65 Oral corticosteroids 65 anakinra 65 FEMALES SHOULD BE ADVISED 65 virologic breakthrough 65 gemcitabine carboplatin 65 Nebulized 65 caspofungin 65 events TEAEs 65 COPEGUS ribavirin 65 ketoconazole 65 STELARA ® 65 Complicated Skin 65 metformin accumulation 65 chronic HCV 65 serum HCV RNA 65 Ribavirin causes 65 Hypokalemia 65 adefovir dipivoxil 65 INTEGRILIN R 65 coinfected patients 65 SVR# 65 Naive Patients 65 DEB# 65 Paraplatin ® 65 mitoxantrone plus 65 Platinol ® 65 clopidogrel Plavix 65 corticosteroid dose 65 ALT normalization 65 CCR5 tropic HIV 65 SinuNase TM 65 peg interferon 65 neutropenic patients 65 curative resection 65 atazanavir ritonavir 65 antiretroviral naïve 65 CIMZIA ™ 65 budesonide pMDI 65 TYGACIL 65 MYLOTARG 65 metastatic malignant melanoma 65 EGFR expressing mCRC 65 venlafaxine Effexor 65 tigecycline 65 Epivir 65 octreotide LAR 65 HAART regimens 65 irbesartan 65 plus methotrexate 65 lumiliximab 65 anaphylactoid reactions 65 mcg QD 65 Hycamtin ® 65 hypokalemia 65 tenofovir DF 65 AGILECT R 65 TMC# r 65 receiving XGEVA 65 Dementia Related Psychosis 65 recurrent GBM 65 VAPRISOL 65 6 mercaptopurine 65 Telithromycin 65 dopaminergic therapy 65 metastatic renal cell carcinoma 65 stage IIIb IV 65 rapid virologic response 65 peripheral sensory neuropathy 65 Toxicities 65 NRTI backbone 65 virus HCV 65 etanercept Enbrel 65 palifermin 65 ergotamine 65 postmenopausal osteoporotic women 65 morphometric vertebral fractures 65 Bezielle 65 antiandrogens 65 docetaxel Taxotere 65 IIIa inhibitor 65 riociguat 65 antithymocyte globulin 65 leflunomide 65 doxorubicin docetaxel 65 cetuximab Erbitux ® 65 pimozide 65 FOLFIRI alone 65 TELINTRA 65 adefovir treated 65 Hepsera adefovir dipivoxil 65 treatment naive genotype 65 darunavir ritonavir 65 partial remissions 65 enalapril 65 FOLFOX6 chemotherapy regimen 65 non squamous NSCLC 65 Tipranavir 65 nucleoside naive 65 Pegloticase 65 metastatic hormone refractory 65 pamidronate 65 oral levofloxacin 65 PEGASYS ® 65 acute gout flares 65 5-fluorouracil/leucovorin 65 liver histology 65 FOLFOX4 65 ddI 65 ARCALYST ® 65 alteplase 65 atazanavir sulfate 65 TNF antagonists 65 OADs 65 bevacizumab Avastin ® 65 steroid dexamethasone 65 null responder 65 vapreotide acetate 65 REVLIMID R 65 atherothrombotic events 65 amprenavir 65 Pegylated Liposomal Doxorubicin 65 Epivir HBV 65 folinic acid 65 combination antiretroviral therapy 64 antiandrogen 64 metformin sulfonylurea 64 galiximab 64 amrubicin 64 nephrotoxic drugs 64 HCV SPRINT 64 Xeloda ® 64 immunosuppressive agents 64 paroxetine Paxil 64 aspirin heparin 64 xanthine oxidase inhibitor 64 AVASTIN 64 CYT# potent vascular disrupting 64 Irinotecan 64 FOLFOX chemotherapy 64 chronic GVHD 64 PREZISTA rtv 64 LEXIVA 64 ara C 64 standard chemotherapy regimens 64 PEG Interferon alfa 64 Serious adverse reactions 64 nitrofurantoin 64 receiving PEGINTRON 64 LEXIVA r 64 HIV coinfected 64 NMIBC 64 trastuzumab Herceptin R 64 plus gemcitabine 64 monoinfected patients 64 sorafenib tablets 64 headache nasopharyngitis 64 RAPTIVA 64 azacitidine 64 Lenalidomide 64 thrombocytopenic 64 #.#mg/dL 64 CTAP# Capsules 64 aldosterone antagonist 64 undetectable viral load 64 adjunctive placebo 64 PEG interferon 64 relapsed SCLC 64 cell lymphoma CTCL 64 melphalan prednisone 64 #mg/m# [001] 64 undetectable HBV DNA 64 Hypersensitivity reactions 64 neutropenic fever 64 hepatic dysfunction 64 proctitis 64 Vidaza azacitidine 64 HBeAg 64 tolvaptan 64 doxorubicin HCl liposome injection 64 low dose cytarabine 64 sunitinib Sutent ® 64 ganciclovir 64 Taxotere ® 64 reduce serum phosphate 64 PEG Intron 64 basiliximab 64 R# #mg BID 64 colorectal liver metastases 64 leukotriene receptor antagonists 64 PEG INTRON R 64 overlapping toxicities 64 pulmonary exacerbations 64 Emtriva Viread 64 thromboembolic complications 64 cyclophosphamide methotrexate 64 HMG CoA reductase inhibitors 64 tinidazole 64 Copegus ® 64 severe hypercholesterolemia 64 dacarbazine DTIC 64 Mitoxantrone 64 Taxotere chemotherapy 64 tenofovir Viread 64 mg TID 64 lamivudine 3TC 64 antibiotic prophylaxis 64 highly emetogenic 64 neurologic progression 64 weekly intravenous infusions 64 danazol 64 HCV genotype 64 terlipressin 64 XELOX 64 mycophenolate 64 leukotriene receptor antagonist 64 chemotherapy induced neutropenia 64 decitabine 64 TYKERB 64 APTIVUS 64 receptor tyrosine kinase inhibitor 64 EGFR TKI 64 chronic idiopathic thrombocytopenic purpura 64 sustained virological response 64 brand ciclesonide HFA 64 Femara letrozole 64 Copegus ® ribavirin 64 FOLFOX4 alone 64 ritonavir boosted lopinavir 64 aspirin clopidogrel 64 nilotinib 64 Capecitabine 64 Combination therapy 64 bevacizumab Avastin R 64 glucocorticoid induced osteoporosis 64 bolus dose 64 ZYVOX 64 Paxil paroxetine 64 Solid Tumors criteria 64 Amgen Neulasta ® 64 canakinumab 64 LOVENOX R 64 coinfected 64 monoamine oxidase inhibitors MAOIs 64 prolonged QT interval 64 atazanavir 64 poor metabolizers 64 zidovudine AZT 64 imatinib Gleevec ® 64 methotrexate therapy 64 cEVR 64 platelet inhibitor 64 purpura ITP 64 ACTOplus met XR 64 Adalimumab 64 Monotherapy 64 pegfilgrastim 64 paclitaxel Taxol 64 hemorrhagic complications 64 GP IIb IIIa inhibitors 64 ceftriaxone 64 Kepivance 64 ELACYT 64 antiplatelet medications 64 combination REBETOL PEG 64 elevated serum creatinine 64 gonococcal infections 64 biochemical relapse 64 dasatinib Sprycel 64 SCIg 64 Dasatinib 64 candesartan cilexetil 64 tranylcypromine 64 micafungin 64 pediatric Crohn disease 64 hematologic abnormalities 64 Natalizumab 64 adalimumab 64 ritonavir boosted atazanavir 64 Gemzar ® 64 prednisone prednisolone 64 genotype 1b 64 undetectable virus HCV 64 e antigen HBeAg 64 herpetic keratitis 64 argatroban 64 ZOMETA 64 bexarotene 64 Gleevec imatinib 64 antiviral therapy 64 ribavirin Copegus ® 64 QT QTc 64 systemically administered 64 BENICAR HCT 64 gemcitabine Gemzar ® 64 antiarrhythmic drugs 64 5 Fluorouracil 64 telaprevir VX 64 mg eq 64 sitaxsentan 64 events SAEs 64 tipranavir r 64 metastatic SCCHN 64 mapatumumab 64 mg BID 64 REMICADE ® 64 renal dysfunction 64 Bevacizumab 64 IV bisphosphonates 64 Pafuramidine 64 ARB telmisartan 64 abatacept 64 CMV infection 64 Perforomist Inhalation Solution 64 BARACLUDE R 64 LHRH analogues 64 leukemia CLL 64 valsartan amlodipine 64 VIIBRYD 64 metastatic castration resistant 64 selective modulator 64 insulin detemir 64 paclitaxel cisplatin 64 incidence ≥ 64 Valcyte 64 irinotecan chemotherapy 64 adenosine injection 64 Fludarabine 64 unresectable HCC 64 methylergonovine 64 evaluable subjects 64 endometrial hyperplasia 64 mitoxantrone 64 ® lenalidomide 64 abacavir sulfate lamivudine 64 NSAID therapy 64 biologic therapy 64 zonisamide SR 64 G CSFs 64 dose corticosteroids 64 trans retinoic acid ATRA 64 pulmonary exacerbation 64 VICTRELIS 64 aminotransferase elevations greater 64 sulfasalazine 64 telaprevir dosed 64 XIENCE V PROMUS Stent 64 noninferior 64 PSA nadir 64 emtricitabine tenofovir 64 zolmitriptan 64 lesinurad 64 virologically 64 drug DMARD 64 #mg QD [001] 64 dopamine partial agonist 64 PEG INTRON 64 efavirenz Sustiva 64 Aflibercept 63 HBV infections 63 Novantrone 63 rilonacept 63 remission induction 63 Refractory Hodgkin Lymphoma 63 QT intervals 63 oxycodone CR 63 transaminase elevations 63 pheochromocytoma 63 TKI therapy 63 alfuzosin 63 panitumumab Vectibix R 63 de novo kidney transplant 63 See CONTRAINDICATIONS 63 perioperatively 63 FIRMAGON 63 daunorubicin 63 heavily pretreated 63 indinavir Crixivan 63 neutropenia thrombocytopenia 63 lipid lowering therapies 63 Oral Fingolimod 63 induce remission 63 leucopenia 63 valopicitabine 63 FluCAM 63 Erythropoietic therapies may 63 non splenectomized 63 splenectomized patients 63 mGluR5 NAM 63 overactive bladder syndrome 63 Alpha interferons including 63 omeprazole Prilosec 63 Fibrillex TM 63 inhibitor RG# 63 octreotide acetate 63 necrotizing pancreatitis 63 nephrotoxic 63 fibrinolysis 63 neutropaenia 63 ribavirin 63 pegylated liposomal doxorubicin 63 paroxetine sertraline 63 AA Amyloidosis 63 undetectable hepatitis C 63 heavily pretreated patients 63 beclomethasone dipropionate 63 novel VDA molecule 63 malignancy HCM 63 aripiprazole Abilify 63 invasive fungal infections 63 PRADAXA 63 bisoprolol 63 previously untreated follicular 63 darunavir r 63 Adjuvant chemotherapy 63 bone marrow reticulin deposition 63 COPEGUS R 63 risperidone Risperdal 63 CR nPR 63 ischemic complications 63 ABRAXANE therapy 63 H2 receptor antagonists 63 relapsed multiple myeloma 63 EFFEXOR XR 63 nucleotide analogue 63 haloperidol Haldol 63 definite stent thrombosis 63 Ranolazine 63 invasive fungal infection 63 intravesical therapy 63 ARIXTRA 63 moderately emetogenic 63 relapsers 63 Vidaza ® 63 nucleoside analogues 63 mild renal insufficiency 63 linezolid 63 KETEK 63 fallopian tube cancers 63 palivizumab 63 Newly Diagnosed Multiple Myeloma 63 IV tPA 63 NRTI 63 vinorelbine 63 glycoprotein IIb IIIa inhibitor 63 Cladribine tablets 63 febrile neutropenia 63 LymphoStat B belimumab 63 post herpetic neuralgia PHN 63 corticosteroids immunoglobulins 63 nonhematologic adverse reactions 63 relapsing remitting MS RRMS 63 renal insufficiency 63 mcg doses 63 cytarabine daunorubicin 63 pharmacologically active isomer 63 nucleoside analog 63 AVODART 63 CRp 63 Kinoid 63 peginterferon alfa 2a #KD 63 non metastatic osteosarcoma 63 eosinophilic asthma 63 RoACTEMRA 63 torsade de pointes 63 R adefovir dipivoxil 63 relapsed ALL 63 Adefovir 63 Copegus 63 mild hepatic impairment 63 generalized edema 63 androgen deprivation 63 STELARA TM 63 cytotoxic chemotherapy 63 grade cervical intraepithelial 63 tamoxifen Nolvadex ® 63 Postoperative complications 63 orally administered inhibitor 63 acetonide FA 63 R metformin Concor 63 EPZICOM 63 carcinoid syndrome 63 dasatinib 63 zafirlukast 63 SSRI SNRI 63 mcg kg 63 conventional DMARDs 63 dose cohort 63 oral methylnaltrexone 63 oral prednisolone 63 Telbivudine 63 hypersensitivity reaction 63 thiazide diuretic 63 Soriatane 63 gastrointestinal stromal tumor GIST 63 adalimumab etanercept 63 citalopram Celexa 63 Platinol ® cisplatin 63 colesevelam HCl 63 Patients Receiving 63 Myelodysplastic Syndrome MDS 63 cabazitaxel 63 NNRTI resistance 63 systemic corticosteroid 63 Pegylated 63 CCR5 tropic 63 MCyR 63 deep venous thromboses 63 Lamivudine 63 neutropenic sepsis 63 BUPHENYL 63 hydroxymethyl coenzyme 63 hepatic insufficiency 63 pegylated liposomal doxorubicin PLD 63 HAART regimen 63 virologic suppression 63 erythropoietic 63 terfenadine 63 relapsed refractory multiple myeloma 63 fallopian tube carcinoma 63 catheter occlusion 63 ULTRAM ER 63 tumors GIST 63 protease inhibitors PIs 63 goserelin 63 anaphylactic reactions bronchospasm 63 Myelosuppression 63 factor TNF 63 lamivudine 63 cytogenetic response 63 ELOXATIN 63 Raptiva r 63 mucosal healing 63 Torsades de Pointes 63 delayed CINV 63 doxorubicin cyclophosphamide 63 MGd 63 CCR5 antagonist 63 thienopyridine 63 antiemetics 63 plasma HCV RNA 63 sertraline Zoloft 63 FOLPI 63 oral antifungal 63 isoniazid 63 J Am Coll 63 epoetin beta 63 daptomycin 63 antidiabetic drug 63 R Saizen R 63 immunosuppressive regimen 63 epithelial tumors 63 liposomal amphotericin B 63 hepatorenal syndrome 63 lopinavir ritonavir Kaletra 63 imipramine Tofranil 63 IV bolus 63 reflux disease GERD 63 d4T stavudine Zerit 63 metastatic colorectal carcinoma 63 stable angina 63 unresectable recurrent 63 olmesartan 63 dose dexamethasone 63 creatinine clearance 63 raltegravir 63 mCRC patients 63 response CCyR 63 rosuvastatin Crestor 63 meropenem 63 quinolone 63 -#.# log# 63 MyVax R 63 mg ustekinumab 63 NATRECOR R 63 hyperphenylalaninemia HPA due 63 hypertrichosis occurred 63 Seliciclib 63 Raptiva ® 63 levofloxacin 63 neutropenic 63 chemoradiation therapy 63 G#DT 63 methimazole 63 chronic HCV genotype 63 bezafibrate 63 infliximab therapy 63 HGS ETR1 mapatumumab 63 headache abdominal pain 63 TNF alpha antagonist 63 thromboembolic events 63 Dose adjustments 63 Febrile neutropenia 63 evaluating tivozanib 63 TAXOTERE R 63 reinfarction 63 atypical antipsychotic medication 63 ACE inhibitor ramipril 63 either acutely decompensated